← Back to Search

Antibiotic

Doxycycline Hcl for COVID-19

Phase 1
Waitlist Available
Research Sponsored by ProgenaBiome
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

Study Summary

This study is evaluating whether a combination of therapies will help individuals with chronic obstructive pulmonary disease.

Eligible Conditions
  • COVID-19
  • Coronavirus
  • Coronavirus Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Efficacy of Treatment as measured by RT-PCR
Efficacy of Treatment as measured by Titer
Time to Non-Infectivity by RT-PCR
+2 more
Secondary outcome measures
Safety of Treatment as Measured by C-Reactive Protein
Safety of Treatment as Measured by Complete Blood Count
Safety of Treatment as Measured by D-Dimer
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Active ArmExperimental Treatment5 Interventions
Patients will be treated with a combination of Ivermectin, Doxycycline, Zinc, Vitamin D3 and Vitamin C
Group II: PlaceboPlacebo Group3 Interventions
Placebo and Vitamin D3, Vitamin C, and Zinc
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Vitamin D3
2011
Completed Phase 4
~3590
Vitamin C
2017
Completed Phase 4
~18470
Ivermectin
2020
Completed Phase 4
~7180
Doxycycline Hcl
2011
Completed Phase 2
~30
Zinc
2005
Completed Phase 4
~17050

Find a Location

Who is running the clinical trial?

ProgenaBiomeLead Sponsor
44 Previous Clinical Trials
5,299 Total Patients Enrolled
6 Trials studying COVID-19
1,268 Patients Enrolled for COVID-19
Topelia TherapeuticsUNKNOWN
Sabine Hazan, MDStudy DirectorProgenaBiome
40 Previous Clinical Trials
4,998 Total Patients Enrolled
6 Trials studying COVID-19
1,268 Patients Enrolled for COVID-19

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Trial of Combination Therapy to Treat COVID-19 Infection
2020. "Trial of Combination Therapy to Treat COVID-19 Infection". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04482686.
All > Covid > Vitamin D
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top